Literature DB >> 1639469

Purification of a Trypanosoma cruzi trypomastigote 60-kilodalton surface glycoprotein that primes and activates murine lymphocytes.

F Villalta1, M F Lima, S A Howard, L Zhou, A Ruiz-Ruano.   

Abstract

We have purified a glycoprotein with a relative molecular mass of 60 kDa and present on the surface of Trypanosoma cruzi trypomastigotes and studied its ability to prime and stimulate the proliferation of murine spleen cells. T. cruzi trypomastigote membrane proteins were separated by preparative isoelectrofocusing. A trypomastigote 60-kDa surface protein with an isoelectric point of 4.2 was enriched by chromatofocusing and was readily purified in native form to homogeneity by gel filtration on a Superose column by use of a fast protein liquid chromatography system. Biotinylated wheat germ agglutinin, Ricinus communis agglutinin, and Datura stramonium agglutinin bound to blots containing the purified trypomastigote 60-kDa surface protein, indicating that this protein was glycosylated. The purified trypomastigote 60-kDa glycoprotein was recognized by antibodies produced during human infection, and immunoglobulin G against the purified glycoprotein immunoprecipitated a biotinylated 60-kDa molecule from the surface of trypomastigotes but not epimastigotes. Specific immunoglobulin G against the 60-kDa glycoprotein also increased the uptake of trypomastigotes and promoted parasite killing by macrophages. The purified 60-kDa glycoprotein was able to specifically activate primed lymphocytes, since there was a significant increase in [3H]thymidine incorporation by spleen cells obtained from CBA mice primed with this glycoprotein, with respect to control values. Furthermore, the 60-kDa glycoprotein did not stimulate unprimed spleen cells, indicating that the lymphoproliferation induced by this glycoprotein was specific and was not due to polyclonal activation. Our findings indicate that this T. cruzi trypomastigote 60-kDa surface glycoprotein primes and activates lymphocytes, which could lead to a beneficial immune response in the host.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639469      PMCID: PMC257277          DOI: 10.1128/iai.60.8.3025-3032.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Multiple peptide synthesis (Pepscan method) for the systematic analysis of B- and T-cell epitopes: Application to parasite proteins.

Authors:  M A Miles; G R Wallace; J L Clarke
Journal:  Parasitol Today       Date:  1989-12

2.  Host-cell attachment by Trypanosoma cruzi: identification of an adhesion molecule.

Authors:  M F Lima; F Villalta
Journal:  Biochem Biophys Res Commun       Date:  1988-08-30       Impact factor: 3.575

3.  Role of inflammatory cells in Chagas' disease. III. Kinetics of human eosinophil activation upon interaction with parasites (Trypanosoma cruzi).

Authors:  F Kierszenbaum; F Villalta; P C Tai
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

4.  Transfusion-associated acute Chagas disease acquired in the United States.

Authors:  I H Grant; J W Gold; M Wittner; H B Tanowitz; C Nathan; K Mayer; L Reich; N Wollner; L Steinherz; F Ghavimi
Journal:  Ann Intern Med       Date:  1989-11-15       Impact factor: 25.391

5.  Transfusion-associated Trypanosoma cruzi infection in a non-endemic area.

Authors:  P Nickerson; P Orr; M L Schroeder; L Sekla; J B Johnston
Journal:  Ann Intern Med       Date:  1989-11-15       Impact factor: 25.391

6.  American trypanosomiasis (Chagas' disease) in Central American immigrants.

Authors:  L V Kirchhoff; A A Gam; F C Gilliam
Journal:  Am J Med       Date:  1987-05       Impact factor: 4.965

7.  The major concanavalin A-binding surface glycoprotein of Leishmania donovani chagasi promastigotes is involved in attachment to human macrophages.

Authors:  M E Wilson; K K Hardin
Journal:  J Immunol       Date:  1988-07-01       Impact factor: 5.422

8.  Chagas' heart disease in the United States.

Authors:  J M Hagar; S H Rahimtoola
Journal:  N Engl J Med       Date:  1991-09-12       Impact factor: 91.245

9.  Fibronectin increases Trypanosoma cruzi amastigote binding to and uptake by murine macrophages and human monocytes.

Authors:  E L Noisin; F Villalta
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

10.  Trypanosoma cruzi trypomastigote clones differentially express a parasite cell adhesion molecule.

Authors:  M F Lima; F Villalta
Journal:  Mol Biochem Parasitol       Date:  1989-03-01       Impact factor: 1.759

View more
  3 in total

1.  Further characterization of protective Trypanosoma cruzi-specific CD4+ T-cell clones: T helper type 1-like phenotype and reactivity with shed trypomastigote antigens.

Authors:  S P Nickell; M Keane; M So
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

2.  The cysteine-cysteine family of chemokines RANTES, MIP-1alpha, and MIP-1beta induce trypanocidal activity in human macrophages via nitric oxide.

Authors:  F Villalta; Y Zhang; K E Bibb; J C Kappes; M F Lima
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

3.  Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection.

Authors:  Anitra L Farrow; Girish Rachakonda; Linlin Gu; Valentina Krendelchtchikova; Pius N Nde; Siddharth Pratap; Maria F Lima; Fernando Villalta; Qiana L Matthews
Journal:  PLoS Negl Trop Dis       Date:  2014-08-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.